1239 related articles for article (PubMed ID: 24076531)
1. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
[TBL] [Abstract][Full Text] [Related]
2. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
[TBL] [Abstract][Full Text] [Related]
3. Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure.
Wang CH; Yang NI; Liu MH; Hsu KH; Kuo LT
Cardiol J; 2016; 23(5):563-572. PubMed ID: 27515479
[TBL] [Abstract][Full Text] [Related]
4. ST2 pathogenetic profile in ambulatory heart failure patients.
Bayes-Genis A; Januzzi JL; Gaggin HK; de Antonio M; Motiwala SR; Zamora E; Galán A; Domingo M; Urrutia A; Lupón J
J Card Fail; 2015 Apr; 21(4):355-61. PubMed ID: 25451702
[TBL] [Abstract][Full Text] [Related]
5. Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure.
Bayes-Genis A; de Antonio M; Galán A; Sanz H; Urrutia A; Cabanes R; Cano L; González B; Díez C; Pascual T; Elosúa R; Lupón J
Eur J Heart Fail; 2012 Jan; 14(1):32-8. PubMed ID: 22179033
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
[TBL] [Abstract][Full Text] [Related]
7. Impact of diabetes on the predictive value of heart failure biomarkers.
Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
[TBL] [Abstract][Full Text] [Related]
8. Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.
Bayes-Genis A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Gastelurrutia P; Vila J; Peñafiel J; Gálvez-Montón C; Lupón J
Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1075-84. PubMed ID: 26297179
[TBL] [Abstract][Full Text] [Related]
9. Renal function largely influences Galectin-3 prognostic value in heart failure.
Zamora E; Lupón J; de Antonio M; Galán A; Domingo M; Urrutia A; Troya M; Bayes-Genis A
Int J Cardiol; 2014 Nov; 177(1):171-7. PubMed ID: 25499371
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP.
Dhillon OS; Narayan HK; Quinn PA; Squire IB; Davies JE; Ng LL
Am Heart J; 2011 Jun; 161(6):1163-70. PubMed ID: 21641364
[TBL] [Abstract][Full Text] [Related]
11. Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes.
Felker GM; Fiuzat M; Thompson V; Shaw LK; Neely ML; Adams KF; Whellan DJ; Donahue MP; Ahmad T; Kitzman DW; Piña IL; Zannad F; Kraus WE; O'Connor CM
Circ Heart Fail; 2013 Nov; 6(6):1172-9. PubMed ID: 24103327
[TBL] [Abstract][Full Text] [Related]
12. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure.
Pascual-Figal DA; Manzano-Fernández S; Boronat M; Casas T; Garrido IP; Bonaque JC; Pastor-Perez F; Valdés M; Januzzi JL
Eur J Heart Fail; 2011 Jul; 13(7):718-25. PubMed ID: 21551163
[TBL] [Abstract][Full Text] [Related]
13. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.
Pascual-Figal DA; Ordoñez-Llanos J; Tornel PL; Vázquez R; Puig T; Valdés M; Cinca J; de Luna AB; Bayes-Genis A;
J Am Coll Cardiol; 2009 Dec; 54(23):2174-9. PubMed ID: 19942089
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure.
Ahmad T; Fiuzat M; Neely B; Neely ML; Pencina MJ; Kraus WE; Zannad F; Whellan DJ; Donahue MP; Piña IL; Adams KF; Kitzman DW; O'Connor CM; Felker GM
JACC Heart Fail; 2014 Jun; 2(3):260-8. PubMed ID: 24952693
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of galectin-3 on admission in Chinese patients with heart failure: a prospective observational study.
Wang H; Chen Q; Li Y; Jing X; Liang T; Yang J
Acta Cardiol; 2017 Apr; 72(2):188-195. PubMed ID: 28597803
[TBL] [Abstract][Full Text] [Related]
16. Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification.
de Antonio M; Lupón J; Galán A; Vila J; Zamora E; Urrutia A; Díez C; Coll R; Altimir S; Bayes-Genis A
Clin Chim Acta; 2013 Nov; 426():18-24. PubMed ID: 23978483
[TBL] [Abstract][Full Text] [Related]
17. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
18. Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients.
Behnes M; Bertsch T; Weiss C; Ahmad-Nejad P; Akin I; Fastner C; El-Battrawy I; Lang S; Neumaier M; Borggrefe M; Hoffmann U
Int J Cardiol; 2016 Jan; 203():398-406. PubMed ID: 26539964
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure.
Rehman SU; Mueller T; Januzzi JL
J Am Coll Cardiol; 2008 Oct; 52(18):1458-65. PubMed ID: 19017513
[TBL] [Abstract][Full Text] [Related]
20. Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients.
Obokata M; Sunaga H; Ishida H; Ito K; Ogawa T; Ando Y; Kurabayashi M; Negishi K
Am Heart J; 2016 Sep; 179():29-41. PubMed ID: 27595677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
